Andreas Behren (A Behren)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 28

Top Venues

Nature medicine

Nature immunology

Nature communications

Cancer immunology research

Olivia Newton-John Cancer Research Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Olivia Newton-John Cancer Research Institute Jan 01 2018

Australia

Head, Tumour Immunology Laboratory :: Cancer Immunobiology

Publications

Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Thomas S Fulford, Caroline Soliman, Rebecca G Castle, Marc Rigau, Zheng Ruan, Olan Dolezal, Rebecca Seneviratna, Hamish G Brown, Eric Hanssen, Andrew Hammet, Shihan Li, Samuel J Redmond, Amy W Chung, Michael A Gorman, Michael W Parker, Onisha Patel, Thomas S Peat, Janet Newman, Andreas Behren, Nicholas A Gherardin, Dale I Godfrey, Adam P Uldrich
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers. Nature immunology 25 (8) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Thomas S Fulford, Caroline Soliman, Rebecca G Castle, Marc Rigau, Zheng Ruan, Olan Dolezal, Rebecca Seneviratna, Hamish G Brown, Eric Hanssen, Andrew Hammet, Shihan Li, Samuel J Redmond, Amy W Chung, Michael A Gorman, Michael W Parker, Onisha Patel, Thomas S Peat, Janet Newman, Andreas Behren, Nicholas A Gherardin, Dale I Godfrey, Adam P Uldrich
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers. Nature immunology (2024)
Ashray Gunjur, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W Haak, Benjamin Markman, Damien Kee, Matteo S Carlino, Underhill Craig, Sophia Frentzas, Michael Michael, Bo Gao, Jodie Palmer, Jonathan Cebon, Andreas Behren, David J Adams, Trevor D Lawley
A gut microbial signature for combination immune checkpoint blockade across cancer types. Nature medicine 30 (3) (2024)
Thomas S Fulford, Caroline Soliman, Rebecca G Castle, Marc Rigau, Zheng Ruan, Olan Dolezal, Rebecca Seneviratna, Hamish G Brown, Eric Hanssen, Andrew Hammet, Shihan Li, Samuel J Redmond, Amy W Chung, Michael A Gorman, Michael W Parker, Onisha Patel, Thomas S Peat, Janet Newman, Andreas Behren, Nicholas A Gherardin, Dale I Godfrey, Adam P Uldrich
Vγ9Vδ2 T cells recognize butyrophilin 2A1 and 3A1 heteromers. Nature immunology 25 (8) (2024)
Marina H Yakou, Sonia Ghilas, Kelly Tran, Yang Liao, Shoukat Afshar-Sterle, Anita Kumari, Kevin Schmid, Christine Dijkstra, Chantelle Inguanti, Simone Ostrouska, Jordan Wilcox, Maxine Smith, Pavitha Parathan, Amr Allam, Hai-Hui Xue, Gabrielle T Belz, John M Mariadason, Andreas Behren, Grant R Drummond, Roland Ruscher, David S Williams, Bhupinder Pal, Wei Shi, Matthias Ernst, Dinesh Raghu, Lisa A Mielke
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Science immunology 8 (88) (2023)
Ashray Gunjur, Andrea J Manrique-Rincón, Oliver Klein, Andreas Behren, Trevor D Lawley, Sarah J Welsh, David J Adams
'Know thyself' - host factors influencing cancer response to immune checkpoint inhibitors. The Journal of pathology 257 (4) (2022)
Jonathan S Cebon, Martin Gore, John F Thompson, Ian D Davis, Grant A McArthur, Euan T Walpole, Bernard Mark Smithers, Vincenzo Cerundolo, P Rod Dunbar, Duncan MacGregor, Cyril Fisher, Michael Millward, Paul Nathan, Michael P N Findlay, Peter Hersey, Thomas R Jeffry Evans, Christian Hermann Ottensmeier, Jeremy Marsden, Angus G Dalgleish, Philippa Corrie, Marples Maria, Margaret A Brimble, Geoff Williams, Sintia Winkler, Heather M Jackson, Liliana Endo-Munoz, Candani S A Tutuka, Ralph Venhaus, Lloyd J Old, Dennis Haack, Eugene Maraskovsky, Andreas Behren, Weisan Chen
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma. Journal for immunotherapy of cancer 8 (1) (2021)
Jessica Da Gama Duarte, Luke T Quigley, Anna Rachel Young, Masaru Hayashi, Mariko Miyazawa, Alex Lopata, Nunzio Mancuso, Mikio Mikami, Andreas Behren, Els N T Meeusen
Identification of Tumor Antigens in Ovarian Cancers Using Local and Circulating Tumor-Specific Antibodies. International journal of molecular sciences 22 (20) (2021)
Jessica Da Gama Duarte, Katherine Woods, Luke T Quigley, Cyril Deceneux, Candani Tutuka, Tom Witkowski, Simone Ostrouska, Chris Hudson, Simon Chang-Hao Tsao, Anupama Pasam, Alexander Dobrovic, Jonathan Michael Blackburn, Jonathan Cebon, Andreas Behren
Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses. Cancers 13 (8) (2021)
Junrong Li, Alain Wuethrich, Abu Ali Ibn Sina, Han-Hao Cheng, Yuling Wang, Andreas Behren, Paul N Mainwaring, Matt Trau
A digital single-molecule nanopillar SERS platform for predicting and monitoring immune toxicities in immunotherapy. Nature communications 12 (1) (2021)
Jason D Lickliter, Hui K Gan, Mark Voskoboynik, Surein Arulananda, Bo Gao, Adnan Nagrial, Peter Grimison, Michelle Harrison, Jianjun Zou, Lianshan Zhang, Stacey Luo, Michael Lahn, Howard Kallender, Andrea Mannucci, Catello Somma, Katherine Woods, Andreas Behren, Pablo Fernandez-Penas, Michael Millward, Tarek Meniawy
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia. Drug design, development and therapy 14 (2020)
Oliver Klein, Damien Kee, Ben Markman, Michael Michael, Craig Underhill, Matteo S Carlino, Louise Jackett, Caroline Lum, Clare L Scott, Adnan Nagrial, Andreas Behren, Jane Y So, Jodie Palmer, Jonathan S Cebon
Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Prashanth Prithviraj, Matthew Anaka, Erik W Thompson, Revati Sharma, Marzena Walkiewicz, Candani S A Tutuka, Andreas Behren, George Kannourakis, Aparna Jayachandran
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes. Scientific reports 10 (1) (2020)
Jing Wang, Alain Wuethrich, Abu Ali Ibn Sina, Rebecca E Lane, Lynlee L Lin, Yuling Wang, Jonathan S Cebon, Andreas Behren, Matt Trau
Tracking extracellular vesicle phenotypic changes enables treatment monitoring in melanoma. Science advances 6 (9) (2020)
Marc Rigau, Simone Ostrouska, Thomas S Fulford, Darryl N Johnson, Katherine Woods, Zheng Ruan, Hamish E G McWilliam, Christopher Hudson, Candani Tutuka, Adam K Wheatley, Stephen J Kent, Jose A Villadangos, Bhupinder Pal, Christian Kurts, Jason Simmonds, Matthias Pelzing, Andrew D Nash, Andrew Hammet, Anne M Verhagen, Gino Vairo, Eugene Maraskovsky, Con Panousis, Nicholas A Gherardin, Jonathan S Cebon, Dale I Godfrey, Andreas Behren, Adam P Uldrich
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells. Science (New York, N.Y.) 367 (6478) (2020)
Pouya Faridi, Katherine Woods, Simone Ostrouska, Cyril Deceneux, Ritchlynn Aranha, Divya Duscharla, Stephen Q Wong, Weisan Chen, Sri H Ramarathinam, Terry C C Lim Kam Sian, Nathan Paul Croft, Chen Li, Rochelle Ayala, Jonathan S Cebon, Anthony Wayne Purcell, Ralf Bernd Schittenhelm, Andreas Behren
Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma. Cancer immunology research 8 (10) (2020)
Erinna F Lee, Tiffany J Harris, Sharon Tran, Marco Evangelista, Surein Arulananda, Thomas John, Celeste Ramnac, Chloe Hobbs, Haoran Zhu, Gency Gunasingh, David Segal, Andreas Behren, Jonathan Cebon, Alexander Dobrovic, John M Mariadason, Andreas Strasser, Leona Rohrbeck, Nikolas K Haass, Marco J Herold, W Douglas Fairlie
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival. Cell death & disease 10 (5) (2019)
Joseph Cursons, Fernando Souza-Fonseca-Guimaraes, Momeneh Foroutan, Ashley Anderson, Frédéric Hollande, Soroor Hediyeh-Zadeh, Andreas Behren, Nicholas D Huntington, Melissa J Davis
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients. Cancer immunology research 7 (7) (2019)
Katharina Hochheiser, Han Xian Aw Yeang, Teagan Wagner, Candani Tutuka, Andreas Behren, Jason Waithman, Christopher Angel, Paul J Neeson, Thomas Gebhardt, David E Gyorki
Accumulation of CD103+ CD8+ T cells in a cutaneous melanoma micrometastasis. Clinical & translational immunology 8 (12) (2019)
H Halse, A J Colebatch, P Petrone, M A Henderson, J K Mills, H Snow, J A Westwood, S Sandhu, J M Raleigh, Andreas Behren, J Cebon, P K Darcy, M H Kershaw, G A McArthur, D E Gyorki, P J Neeson
Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma. Scientific reports 8 (1) (2018)
Simon Chang-Hao Tsao, Jing Wang, Yuling Wang, Andreas Behren, Jonathan Cebon, Matt Trau
Characterising the phenotypic evolution of circulating tumour cells during treatment. Nature communications 9 (1) (2018)
Jessica Da Gama Duarte, Katherine Woods, Miles C Andrews, Andreas Behren
The good, the (not so) bad and the ugly of immune homeostasis in melanoma. Immunology and cell biology 96 (5) (2018)
Candani S A Tutuka, Miles C Andrews, John M Mariadason, Paul Ioannidis, Christopher Hudson, Jonathan Cebon, Andreas Behren
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation. Molecular cancer 16 (1) (2017)

Andreas Behren.css-eqlu8i{font-size:small;padding-left:4px;} (A Behren)

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Behren (A Behren)